Threatened Abortion Clinical Trial
— POTAOfficial title:
Pregnancy Outcome in Woman With Threatened Abortion
| Verified date | February 2016 |
| Source | Bnai Zion Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Israel: Ministry of Health |
| Study type | Observational |
The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.
| Status | Completed |
| Enrollment | 3000 |
| Est. completion date | January 2016 |
| Est. primary completion date | January 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Women who attended the Emergency department with vaginal bleeding and/or abdominal pain and were on their 20th week of pregnancy or less. Exclusion Criteria: - Women with any background that can explain vaginal bleeding or any other circumstance that can explain it. |
Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Bnai Zion Medical Center |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Maternal and neonatal outcome in pregnancies with 1st and 2nd trimester bleeding | by using our data in the past 7 years we will examine retrospectively cases of patients from their first admission due to vaginal bleeding throgh their pregnancy and labor . the mesearment will include : Intra uterine growth retardation , Antepartum hemorrhage, premature rupture of membrane, Intra uterine fetal death , Preterm delivery, Apgar less than 7, Congenital malformation, Mode of delivery - vaginal delivery vs. cesarean section |
9 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02420769 -
Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion
|
N/A | |
| Withdrawn |
NCT01501890 -
Progesterone for First Trimester Vaginal Bleeding
|
N/A | |
| Completed |
NCT03930212 -
Progesterone Supplementation in Threatened Abortion
|
Phase 4 | |
| Completed |
NCT04788108 -
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
|
Phase 4 |